Calcium acetate (BioDeep_00000858399)
代谢物信息卡片
Calcium acetate
化学式: C4H6CaO4 (157.9891986)
中文名称: 醋酸钙
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: CC(=O)[O-].CC(=O)[O-].[Ca+2]
InChI: /q
描述信息
V - Various > V03 - All other therapeutic products > V03A - All other therapeutic products > V03AE - Drugs for treatment of hyperkalemia and hyperphosphatemia
D064449 - Sequestering Agents > D002614 - Chelating Agents
同义名列表
1 个代谢物同义名
数据库引用编号
6 个数据库交叉引用编号
- ChEBI: CHEBI:3310
- KEGGdrug: D00931
- PubChem: 6116
- DrugBank: DB00258
- ChEMBL: CHEMBL1200800
- CAS: 62-54-4
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Ana Merino-Ribas, Ricardo Araujo, Ioana Bancu, Fredzzia Graterol, Andrea Vergara, Marc Noguera-Julian, Roger Paredes, Jordi Bonal, Benedita Sampaio-Maia. Gut microbiome in hemodialysis patients treated with calcium acetate or treated with sucroferric oxyhydroxide: a pilot study.
International urology and nephrology.
2022 Aug; 54(8):2015-2023. doi:
10.1007/s11255-021-03091-3. [PMID: 34923600] - Darius L Mason, Kavitha Godugu, Daryl Nnani, Shaker A Mousa. Effects of sevelamer carbonate versus calcium acetate on vascular calcification, inflammation, and endothelial dysfunction in chronic kidney disease.
Clinical and translational science.
2022 02; 15(2):353-360. doi:
10.1111/cts.13151. [PMID: 34599865] - Dorien Groenendaal-van de Meent, Virginie Kerbusch, Begona Barroso-Fernandez, Martin den Adel, Jan van Dijk, Georg Golor, Marloes Schaddelee. Effect of the Phosphate Binders Sevelamer Carbonate and Calcium Acetate on the Pharmacokinetics of Roxadustat After Concomitant or Time-separated Administration in Healthy Individuals.
Clinical therapeutics.
2021 06; 43(6):1079-1091. doi:
10.1016/j.clinthera.2021.03.025. [PMID: 33962762] - Charles Ginsberg, Leila R Zelnick, Geoffrey A Block, Glenn M Chertow, Michel Chonchol, Andrew Hoofnagle, Bryan Kestenbaum, Ian H de Boer. Differential effects of phosphate binders on vitamin D metabolism in chronic kidney disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2020 04; 35(4):616-623. doi:
10.1093/ndt/gfaa010. [PMID: 32160298] - Nathan Price, Tao Fei, Stephanie Clark, Tong Wang. Application of zinc and calcium acetate to precipitate milk fat globule membrane components from a dairy by-product.
Journal of dairy science.
2020 Feb; 103(2):1303-1314. doi:
10.3168/jds.2019-16892. [PMID: 31759589] - Karin Purshouse, Sarah Chamberlain, Maria Soares, Mark Tuthill, Andrew Protheroe, David R Mole. Case report of oxalate nephropathy in a patient with pancreatic metastases from renal carcinoma.
BMC cancer.
2019 Oct; 19(1):967. doi:
10.1186/s12885-019-6215-y. [PMID: 31623580] - Barbara Clark, Mohammad Wisam Baqdunes, Gregory M Kunkel. Diet-induced oxalate nephropathy.
BMJ case reports.
2019 Sep; 12(9):. doi:
10.1136/bcr-2019-231284. [PMID: 31527218] - C Treesubsuntorn, P Thiravetyan. Calcium acetate-induced reduction of cadmium accumulation in Oryza sativa: Expression of auto-inhibited calcium-ATPase and cadmium transporters.
Plant biology (Stuttgart, Germany).
2019 Sep; 21(5):862-872. doi:
10.1111/plb.12990. [PMID: 30924996] - Zhongbing Liu, Xuemei Sun, Tiantian Liang, Yi Luo, Xiaoyan Chen, Ting Li, Lin Chen, Junjie Wang, Yan Lin, Yun Ye, Zhirong Zhong. Preparation and Characterization of the Biological Compound Effervescent Granule of Calcium Acetate.
Current pharmaceutical biotechnology.
2019; 20(11):934-944. doi:
10.2174/1389201020666190628144637. [PMID: 31264545] - Jang-Hee Cho, Hye Min Jang, Hee-Yeon Jung, Ji-Young Choi, Sun-Hee Park, Chan-Duck Kim, Chul Woo Yang, Dong-Chan Jin, Yong-Lim Kim. A Real-world Cost-effectiveness Analysis of Sevelamer Versus Calcium Acetate in Korean Dialysis Patients.
Clinical therapeutics.
2018 01; 40(1):123-134. doi:
10.1016/j.clinthera.2017.02.005. [PMID: 28291581] - William Colonna, Byron Brehm-Stecher, Kalidas Shetty, Anthony Pometto. Rapid Screening of Natural Plant Extracts with Calcium Diacetate for Differential Effects Against Foodborne Pathogens and a Probiotic Bacterium.
Foodborne pathogens and disease.
2017 12; 14(12):719-727. doi:
10.1089/fpd.2017.2284. [PMID: 28910141] - Michael Copland, Paul Komenda, Eric D Weinhandl, Peter A McCullough, Jose A Morfin. Intensive Hemodialysis, Mineral and Bone Disorder, and Phosphate Binder Use.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2016 Nov; 68(5S1):S24-S32. doi:
10.1053/j.ajkd.2016.05.024. [PMID: 27772640] - Timothy Nguyen, Trung Pham, Tommy Huynh. Phosphate binder choices used in ESRD patients.
Nephrology news & issues.
2016 Aug; 30(8):37-38. doi:
NULL. [PMID: 30513170] - Sergey V Gnedenkov, Sergey L Sinebryukhov, Artyom V Puz, Vladimir S Egorkin, Roman E Kostiv. In vivo study of osteogenerating properties of calcium-phosphate coating on titanium alloy Ti-6Al-4V.
Bio-medical materials and engineering.
2016; 27(6):551-560. doi:
10.3233/bme-161608. [PMID: 28234240] - Zhuangzhu Liu, Guobin Su, Xinfeng Guo, Yifan Wu, Xusheng Liu, Chuan Zou, Lei Zhang, Qianchun Yang, Yuan Xu, Weizhong Ma. Dietary interventions for mineral and bone disorder in people with chronic kidney disease.
The Cochrane database of systematic reviews.
2015 Sep; ?(9):CD010350. doi:
10.1002/14651858.cd010350.pub2. [PMID: 26376110] - Peter N Van Buren, Julia B Lewis, Jamie P Dwyer, Tom Greene, John Middleton, Mohammed Sika, Kausik Umanath, Josephine D Abraham, Shahabul S Arfeen, Isai G Bowline, Gil Chernin, Stephen Z Fadem, Simin Goral, Mark Koury, Marvin V Sinsakul, Daniel E Weiner. The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2015 Sep; 66(3):479-88. doi:
10.1053/j.ajkd.2015.03.013. [PMID: 25958079] - Adenike Okunlola, Oluwatoyin A Odeku, Alf Lamprecht, Ademola A Oyagbemi, Olayinka A Oridupa, Oluwasanmi O Aina. Design of cissus-alginate microbeads revealing mucoprotection properties in anti-inflammatory therapy.
International journal of biological macromolecules.
2015 Aug; 79(?):226-34. doi:
10.1016/j.ijbiomac.2015.04.062. [PMID: 25940525] - Yong Wang, Guoqiang Xie, Yuanhang Huang, Han Zhang, Bo Yang, Zhiguo Mao. Calcium acetate or calcium carbonate for hyperphosphatemia of hemodialysis patients: a meta-analysis.
PloS one.
2015; 10(3):e0121376. doi:
10.1371/journal.pone.0121376. [PMID: 25799184] - Vincenzo Panichi, Alberto Rosati, Adriana Di Giorgio, Alessia Scatena, Roberto Bigazzi, Giovanni Grazi, Massimiliano Migliori, Sabrina Paoletti, Giovanni Manca Rizza, Aldo Casani, Alessandro Sgambato, Matteo Ruggeri. A pharmacoeconomic analysis of phosphate binders cost-effectiveness in the RISCAVID study.
Blood purification.
2015; 39(1-3):174-180. doi:
10.1159/000369957. [PMID: 25765293] - Ahuva Cern, Einat Nativ-Roth, Amiram Goldblum, Yechezkel Barenholz. Effect of solubilizing agents on mupirocin loading into and release from PEGylated nanoliposomes.
Journal of pharmaceutical sciences.
2014 Jul; 103(7):2131-2138. doi:
10.1002/jps.24037. [PMID: 24898012] - Akeem A Yusuf, Eric D Weinhandl, Wendy L St Peter. Comparative effectiveness of calcium acetate and sevelamer on clinical outcomes in elderly hemodialysis patients enrolled in Medicare part D.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2014 Jul; 64(1):95-103. doi:
10.1053/j.ajkd.2013.11.015. [PMID: 24387795] - Viken A Prajapati, Varsha J Galani, Pankaj R Shah. A comparative study of phosphate binders in patients with end stage kidney disease undergoing hemodialysis.
Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.
2014 May; 25(3):530-8. doi:
10.4103/1319-2442.132167. [PMID: 24821148] - Steven Wang, Emmanuel A Anum, Karthik Ramakrishnan, Thomas Alfieri, Peter Braunhofer, Britt Newsome. Reasons for phosphate binder discontinuation vary by binder type.
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
2014 Mar; 24(2):105-9. doi:
10.1053/j.jrn.2013.11.004. [PMID: 24462496] - David Arroyo, Nayara Panizo, Soraya Abad, Almudena Vega, Ana Pérez-de José, Juan M López-Gómez. The effect of replacing aluminium hydroxide with calcium acetate/magnesium carbonate on serum phosphorus control in haemodialysis patients.
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.
2014; 34(2):199-204. doi:
10.3265/nefrologia.pre2013.nov.12145. [PMID: 24658194] - Angel L M de Francisco, Lara Belmar, Celestino Piñera, María Kislikova, Miguel Seras, Mara Serrano, Zoila Albines, Cristina Sango, Manuel Arias. Effect of calcium acetate/magnesium carbonate in the treatment of hyperphosphataemia in dialysis patients in real clinical practice. One year follow up.
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.
2014; 34(5):617-27. doi:
10.3265/nefrologia.pre2014.jul.12527. [PMID: 25259817] - Ellen Neven, Tineke M De Schutter, Geert Dams, Kristina Gundlach, Sonja Steppan, Janine Büchel, Jutta Passlick-Deetjen, Patrick C D'Haese, Geert J Behets. A magnesium based phosphate binder reduces vascular calcification without affecting bone in chronic renal failure rats.
PloS one.
2014; 9(9):e107067. doi:
10.1371/journal.pone.0107067. [PMID: 25229549] - Sophie A Jamal, Ben Vandermeer, Paolo Raggi, David C Mendelssohn, Trish Chatterley, Marlene Dorgan, Charmaine E Lok, David Fitchett, Ross T Tsuyuki. Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis.
Lancet (London, England).
2013 Oct; 382(9900):1268-77. doi:
10.1016/s0140-6736(13)60897-1. [PMID: 23870817] - Rodrigo B de Oliveira, Fabiana G Graciolli, Luciene M dos Reis, Ana L E Cancela, Lilian Cuppari, Maria E Canziani, Aluizio B Carvalho, Vanda Jorgetti, Rosa M A Moysés. Disturbances of Wnt/β-catenin pathway and energy metabolism in early CKD: effect of phosphate binders.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2013 Oct; 28(10):2510-7. doi:
10.1093/ndt/gft234. [PMID: 23975746] - Adrian Covic, Jutta Passlick-Deetjen, Miroslaw Kroczak, Beatrix Büschges-Seraphin, Adrian Ghenu, Pedro Ponce, Barbara Marzell, Angel L M de Francisco. A comparison of calcium acetate/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: post hoc evaluation from a controlled, randomized study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2013 Sep; 28(9):2383-92. doi:
10.1093/ndt/gft203. [PMID: 23787550] - Susan J Allison. Chronic kidney disease: calcium-based versus non-calcium-based phosphate binders: effect on mortality in patients with CKD.
Nature reviews. Nephrology.
2013 09; 9(9):491. doi:
10.1038/nrneph.2013.132. [PMID: 23917795] - Tineke M De Schutter, Geert J Behets, Hilde Geryl, Mirjam E Peter, Sonja Steppan, Kristina Gundlach, Jutta Passlick-Deetjen, Patrick C D'Haese, Ellen Neven. Effect of a magnesium-based phosphate binder on medial calcification in a rat model of uremia.
Kidney international.
2013 Jun; 83(6):1109-17. doi:
10.1038/ki.2013.34. [PMID: 23486515] - Melanie Gorman Ng, Stan de Poot, Kaspar Schmid, Hilary Cowie, Sean Semple, Martie van Tongeren. Properties of liquids and dusts: how do they influence dermal loading during immersion, deposition, and surface contact exposure pathways?.
The Annals of occupational hygiene.
2013 Jun; 57(5):627-39. doi:
10.1093/annhyg/mes101. [PMID: 23316077] - Indranil Dasgupta, Rukshana Shroff, David Bennett-Jones, Gary McVeigh. Management of hyperphosphataemia in chronic kidney disease: summary of National Institute for Health and Clinical Excellence (NICE) guideline.
Nephron. Clinical practice.
2013; 124(1-2):1-9. doi:
10.1159/000354711. [PMID: 24022619] - Pieter Evenepoel, Bjorn Meijers. Chronic kidney disease: Phosphate binder therapy--cracks in the tower of strength?.
Nature reviews. Nephrology.
2012 Nov; 8(11):615-6. doi:
10.1038/nrneph.2012.219. [PMID: 23045230] - Tsung-Jui Wu, Ying-Tang Wang, Hung Chang, Shih-Hua Lin. Parathyromatosis.
Kidney international.
2012 Nov; 82(10):1140. doi:
10.1038/ki.2012.257. [PMID: 23128122] - Geoffrey A Block, David C Wheeler, Martha S Persky, Bryan Kestenbaum, Markus Ketteler, David M Spiegel, Matthew A Allison, John Asplin, Gerard Smits, Andrew N Hoofnagle, Laura Kooienga, Ravi Thadhani, Michael Mannstadt, Myles Wolf, Glenn M Chertow. Effects of phosphate binders in moderate CKD.
Journal of the American Society of Nephrology : JASN.
2012 Aug; 23(8):1407-15. doi:
10.1681/asn.2012030223. [PMID: 22822075] - Mahmut Ilker Yilmaz, Alper Sonmez, Mutlu Saglam, Halil Yaman, Selim Kilic, Tayfun Eyileten, Kayser Caglar, Yusuf Oguz, Abdulgaffar Vural, Mujdat Yenicesu, Francesca Mallamaci, Carmine Zoccali. Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trial.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2012 Feb; 59(2):177-85. doi:
10.1053/j.ajkd.2011.11.007. [PMID: 22137672] - Paweena Susantitaphong, Bertrand L Jaber. Potential interaction between sevelamer and fat-soluble vitamins: a hypothesis.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2012 Feb; 59(2):165-7. doi:
10.1053/j.ajkd.2011.12.001. [PMID: 22243944] - Anne M Huml, Catherine M Sullivan, Janeen B Leon, Ashwini R Sehgal. The adequacy of phosphorus binder prescriptions among American hemodialysis patients.
Renal failure.
2012; 34(10):1258-63. doi:
10.3109/0886022x.2012.718724. [PMID: 23013171] - Diana Moldovan, Ioan Moldovan, Crina Rusu, Simona Racasan, Ioan M Patiu, Adrian Brumboiu, Cosmina Bondor, Liliana Parvu, Ina Kacso, Remus Orasan, Mirela Gherman-Caprioara. Vascular calcifications and renal osteodystrophy in chronic hemodialysis patients: what is the relationship between them?.
International urology and nephrology.
2011 Dec; 43(4):1179-86. doi:
10.1007/s11255-010-9841-5. [PMID: 20862543] - Alastair J Hutchison, Craig P Smith, Paul E C Brenchley. Pharmacology, efficacy and safety of oral phosphate binders.
Nature reviews. Nephrology.
2011 Sep; 7(10):578-89. doi:
10.1038/nrneph.2011.112. [PMID: 21894188] - Juan F Navarro-González, Carmen Mora-Fernández, Mercedes Muros de Fuentes, Javier Donate-Correa, Violeta Cazaña-Pérez, Javier García-Pérez. Effect of phosphate binders on serum inflammatory profile, soluble CD14, and endotoxin levels in hemodialysis patients.
Clinical journal of the American Society of Nephrology : CJASN.
2011 Sep; 6(9):2272-9. doi:
10.2215/cjn.01650211. [PMID: 21784820] - Yalcin Solak, Zeynep Biyik, Orhan Ozbek, Sinan Demircioglu, Suleyman Turk. Spontaneous bilateral humeral shaft fracture due to severe renal osteodystrophia.
The American journal of the medical sciences.
2011 Jul; 342(1):55. doi:
10.1097/maj.0b013e31820ff98e. [PMID: 21537152] - Linda Noto. Lanthanum carbonate provides control of phosphorus levels in patients new to phosphate binder therapy and patients changed from other phosphate binders.
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
2011 May; 21(3):277-82. doi:
10.1053/j.jrn.2010.04.007. [PMID: 20598905] - Isabelle Zamfirescu, Harold E Carlson. Absorption of levothyroxine when coadministered with various calcium formulations.
Thyroid : official journal of the American Thyroid Association.
2011 May; 21(5):483-6. doi:
10.1089/thy.2010.0296. [PMID: 21595516] - Leonardo V Riella, Helmut G Rennke, Monica Grafals, Anil Chandraker. Hypophosphatemia in kidney transplant recipients: report of acute phosphate nephropathy as a complication of therapy.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2011 Apr; 57(4):641-5. doi:
10.1053/j.ajkd.2010.11.024. [PMID: 21333424] - Wajeh Qunibi, Wolfgang C Winkelmayer, Richard Solomon, Moustafa Moustafa, Paul Kessler, Chiang-Hong Ho, Jonathan Greenberg, Jose A Diaz-Buxo. A randomized, double-blind, placebo-controlled trial of calcium acetate on serum phosphorus concentrations in patients with advanced non-dialysis-dependent chronic kidney disease.
BMC nephrology.
2011 Feb; 12(?):9. doi:
10.1186/1471-2369-12-9. [PMID: 21324193] - Ana L E Cancela, Rodrigo B Oliveira, Fabiana G Graciolli, Luciene M dos Reis, Fellype Barreto, Daniela V Barreto, Lilian Cuppari, Vanda Jorgetti, Aluizio B Carvalho, Maria Eugênia Canziani, Rosa M A Moysés. Fibroblast growth factor 23 in hemodialysis patients: effects of phosphate binder, calcitriol and calcium concentration in the dialysate.
Nephron. Clinical practice.
2011; 117(1):c74-82. doi:
10.1159/000319650. [PMID: 20689328] - Ashima Gulati, Vijesh Sridhar, Tathagata Bose, Pankaj Hari, Arvind Bagga. Short-term efficacy of sevelamer versus calcium acetate in patients with chronic kidney disease stage 3-4.
International urology and nephrology.
2010 Dec; 42(4):1055-62. doi:
10.1007/s11255-009-9688-9. [PMID: 20020207] - Angel L M de Francisco, Michael Leidig, Adrian C Covic, Markus Ketteler, Ewa Benedyk-Lorens, Gabriel M Mircescu, Caecilia Scholz, Pedro Ponce, Jutta Passlick-Deetjen. Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2010 Nov; 25(11):3707-17. doi:
10.1093/ndt/gfq292. [PMID: 20530499] - Yu-Feng Lin, Yung-Ming Chen, Kuan-Yu Hung, Tzong-Shinn Chu, Wei-Chih Kan, Chih-Yuan Huang, Shuei-Liong Lin, Tze-Wah Kao, Jenq-Wen Huang, Wen-Chih Chiang, Chung-Jen Yen, Tun-Jun Tsai, Kwan-Dun Wu, Ming-Shiou Wu. Benefits of sevelamer on markers of bone turnover in Taiwanese hemodialysis patients.
Journal of the Formosan Medical Association = Taiwan yi zhi.
2010 Sep; 109(9):663-72. doi:
10.1016/s0929-6646(10)60107-6. [PMID: 20863994] - Tae Hee Kim, Sung Yeun Yang. Stomach calcification revealed by gastrofibroscopy in a haemodialysis patient.
Nephrology (Carlton, Vic.).
2010 Aug; 15(5):592-3. doi:
10.1111/j.1440-1797.2010.01210.x. [PMID: 20649883] - Charles J Diskin, Thomas J Stokes, Linda M Dansby, Lautrec Radcliff, Thomas B Carter. Can omeprazole reduce the incidence of hypercalcemia in dialysis patients using calcium containing phosphate binders?.
Journal of nephrology.
2010 Jul; 23(4):438-43. doi:
NULL. [PMID: 20349423] - Rodrigo B Oliveira, Ana L E Cancela, Fabiana G Graciolli, Luciene M Dos Reis, Sérgio A Draibe, Lilian Cuppari, Aluizio B Carvalho, Vanda Jorgetti, Maria E Canziani, Rosa M A Moysés. Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?.
Clinical journal of the American Society of Nephrology : CJASN.
2010 Feb; 5(2):286-91. doi:
10.2215/cjn.05420709. [PMID: 19965540] - Frank Gotch, Nathan W Levin, Peter Kotanko. Calcium balance in dialysis is best managed by adjusting dialysate calcium guided by kinetic modeling of the interrelationship between calcium intake, dose of vitamin D analogues and the dialysate calcium concentration.
Blood purification.
2010; 29(2):163-76. doi:
10.1159/000245924. [PMID: 20093823] - M D Arenas, T Malek, F Álvarez-Ude, M T Gil, A Moledous, A Reig-Ferrer. [Phosphorus binders: preferences of patients on haemodialysis and its impact on treatment compliance and phosphorus control].
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.
2010; 30(5):522-30. doi:
10.3265/nefrologia.pre2010.may.10275. [PMID: 20613851] - Magdalene M Assimon, Shaker Mousa, Olfat Shaker, Amy Barton Pai. The effect of sevelamer hydrochloride and calcium-based phosphate binders on mortality in hemodialysis patients: a need for more research.
The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists.
2010 Jan; 25(1):41-54. doi:
10.4140/tcp.n.2010.41. [PMID: 20211816] - Wendy L St Peter, Qiao Fan, Eric Weinhandl, Jiannong Liu. Economic evaluation of sevelamer versus calcium-based phosphate binders in hemodialysis patients: a secondary analysis using centers for Medicare & Medicaid services data.
Clinical journal of the American Society of Nephrology : CJASN.
2009 Dec; 4(12):1954-61. doi:
10.2215/cjn.04100609. [PMID: 19833904] - Sankar D Navaneethan, Suetonia C Palmer, Jonathan C Craig, Grahame J Elder, Giovanni F M Strippoli. Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2009 Oct; 54(4):619-37. doi:
10.1053/j.ajkd.2009.06.004. [PMID: 19692157] - Sophie A Jamal, David Fitchett, Charmaine E Lok, David C Mendelssohn, Ross T Tsuyuki. The effects of calcium-based versus non-calcium-based phosphate binders on mortality among patients with chronic kidney disease: a meta-analysis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2009 Oct; 24(10):3168-74. doi:
10.1093/ndt/gfp350. [PMID: 19622572] - Aline T Peres, Maria A Dalboni, Maria E Canziani, Silvia R Manfredi, Jose Tarcisio G Carvalho, Marcelo C Batista, Lilian Cuppari, Aluisio B Carvalho, Rosa M A Moyses, Nadia Guimarães, Vanda Jorgetti, Maria C Andreoli, Sergio A Draibe, Miguel Cendoroglo. Effect of phosphate binders on oxidative stress and inflammation markers in hemodialysis patients.
Hemodialysis international. International Symposium on Home Hemodialysis.
2009 Jul; 13(3):271-7. doi:
10.1111/j.1542-4758.2009.00369.x. [PMID: 19614761] - Ismail Mohammed, Alastair J Hutchison. Oral phosphate binders for the management of serum phosphate levels in dialysis patients.
Journal of renal care.
2009 Mar; 35 Suppl 1(?):65-70. doi:
10.1111/j.1755-6686.2009.00052.x. [PMID: 19222734] - Monique Elseviers, Jean-Yves De Vos. The use of phosphate binders: data from contributors to the European Practice Database.
Journal of renal care.
2009 Mar; 35 Suppl 1(?):14-8. doi:
10.1111/j.1755-6686.2009.00051.x. [PMID: 19222726] - Dilshad Ahmad Khan, Fatima-Tuz-Zuhra, Farooq Ahmad Khan, Imran Saif. Assessment of bone mineral metabolism derangements by K/DOQI guidelines in haemodialysis patients at Rawalpindi.
JPMA. The Journal of the Pakistan Medical Association.
2009 Feb; 59(2):64-7. doi:
NULL. [PMID: 19260564] - Pieter Evenepoel, Rafael Selgas, Flavia Caputo, Lukas Foggensteiner, James G Heaf, Alberto Ortiz, Alison Kelly, Scott Chasan-Taber, Ajay Duggal, Stanley Fan. Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2009 Jan; 24(1):278-85. doi:
10.1093/ndt/gfn488. [PMID: 18820280] - Daniela Veit Barreto, Fellype de Carvalho Barreto, Aluízio Barbosa de Carvalho, Lilian Cuppari, Sérgio Antonio Draibe, Maria Aparecida Dalboni, Rosa Maria Affonso Moyses, Kátia Rodrigues Neves, Vanda Jorgetti, Márcio Miname, Raul D Santos, Maria Eugênia F Canziani. Association of changes in bone remodeling and coronary calcification in hemodialysis patients: a prospective study.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2008 Dec; 52(6):1139-50. doi:
10.1053/j.ajkd.2008.06.024. [PMID: 18824289] - Wajeh Qunibi, Larry R Muenz. Progression of calcification in the Calcium Acetate Renagel Evaluation-2 (CARE-2) Study.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2008 Nov; 52(5):1022-3; author reply 1023. doi:
10.1053/j.ajkd.2008.07.043. [PMID: 18971017] - Anthony J Bleyer. Hyperphosphatemia in the Calcium Acetate Renagel Evaluation-2 (CARE-2) Study.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2008 Nov; 52(5):1024; author reply 1025. doi:
10.1053/j.ajkd.2008.06.034. [PMID: 18971019] - Hai-ping Xiao, Jing-tao Li, Jun-hu Zhou, Bao-min Sun, Li-ping Ye. [Pore structure and desulfurization characteristics of organic calcium].
Huan jing ke xue= Huanjing kexue.
2008 Aug; 29(8):2361-5. doi:
". [PMID: 18839601] - Wajeh Qunibi, Moustafa Moustafa, Larry R Muenz, David Y He, Paul D Kessler, Jose A Diaz-Buxo, Mathew Budoff. A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2008 Jun; 51(6):952-65. doi:
10.1053/j.ajkd.2008.02.298. [PMID: 18423809] - F C Barreto, D V Barreto, R M A Moysés, K R Neves, M E F Canziani, S A Draibe, V Jorgetti, A B Carvalho. K/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients.
Kidney international.
2008 Mar; 73(6):771-7. doi:
10.1038/sj.ki.5002769. [PMID: 18185506] - Wolfgang C Winkelmayer, Marcello Tonelli. Phosphate binder choice in dialysis patients: a call for evidence-based rather than marketing-based clinical practice.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2008 Mar; 51(3):362-5. doi:
10.1053/j.ajkd.2008.01.004. [PMID: 18295050] - Wendy L St Peter, Jiannong Liu, Eric Weinhandl, Qiao Fan. A comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and morbidity in hemodialysis: a secondary analysis of the Dialysis Clinical Outcomes Revisited (DCOR) randomized trial using claims data.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2008 Mar; 51(3):445-54. doi:
10.1053/j.ajkd.2007.12.002. [PMID: 18295060] - Kayser Caglar, Mahmut Ilker Yilmaz, Mutlu Saglam, Erdinc Cakir, Cengizhan Acikel, Tayfun Eyileten, Mujdat Yenicesu, Yusuf Oguz, Abdulgaffar Vural, Juan Jesus Carrero, Jonas Axelsson, Bengt Lindholm, Peter Stenvinkel. Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients.
Clinical journal of the American Society of Nephrology : CJASN.
2008 Jan; 3(1):61-8. doi:
10.2215/cjn.02810707. [PMID: 18057307] - Matthew J Budoff, Paul Kessler, Yan L Gao, Wajeh Qunibi, Moustafa Moustafa, Song S Mao. The interscan variation of CT coronary artery calcification score: analysis of the Calcium Acetate Renagel Comparison (CARE)-2 study.
Academic radiology.
2008 Jan; 15(1):58-61. doi:
10.1016/j.acra.2007.08.011. [PMID: 18078907] - W N Suki, R Zabaneh, J L Cangiano, J Reed, D Fischer, L Garrett, B N Ling, S Chasan-Taber, M A Dillon, A T Blair, S K Burke. Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients.
Kidney international.
2007 Nov; 72(9):1130-7. doi:
10.1038/sj.ki.5002466. [PMID: 17728707] - Imran Saif, Abdul Halim, Ashfaq Altaf, Mohsin Saif, Muhammad Khalid, Dilshad Ahmad, Humera Imran. Comparison of calcium acetate with calcium carbonate as phosphate binder in patients on maintenance haemodialysis.
Journal of Ayub Medical College, Abbottabad : JAMC.
2007 Oct; 19(4):26-8. doi:
. [PMID: 18693591] - Avi Schroeder, Yuval Avnir, Sarah Weisman, Yousef Najajreh, Alberto Gabizon, Yeshayahu Talmon, Joseph Kost, Yechezkel Barenholz. Controlling liposomal drug release with low frequency ultrasound: mechanism and feasibility.
Langmuir : the ACS journal of surfaces and colloids.
2007 Mar; 23(7):4019-25. doi:
10.1021/la0631668. [PMID: 17319706] - Andrea Galassi, David M Spiegel, Antonio Bellasi, Geoffrey A Block, Paolo Raggi. Accelerated vascular calcification and relative hypoparathyroidism in incident haemodialysis diabetic patients receiving calcium binders.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2006 Nov; 21(11):3215-22. doi:
10.1093/ndt/gfl395. [PMID: 16877490] - Vincenzo Savica, Lorenzo A Calò, Pietro Monardo, Domenico Santoro, Guido Bellinghieri. Phosphate binders and management of hyperphosphataemia in end-stage renal disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2006 Aug; 21(8):2065-8. doi:
10.1093/ndt/gfl289. [PMID: 16766546] - Tilman B Drüeke, Paul Landais. Paricalcitol for treatment of secondary hyperparathyroidism in CKD patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2006 Jun; 47(6):1083; author reply 1083-4. doi:
10.1053/j.ajkd.2006.02.191. [PMID: 16731305] - Ursula C Brewster, Marc A Ciampi, Ali K Abu-Alfa, Robert F Reilly. Long-term comparison of sevelamer hydrochloride to calcium-containing phosphate binders.
Nephrology (Carlton, Vic.).
2006 Apr; 11(2):142-6. doi:
10.1111/j.1440-1797.2006.00544.x. [PMID: 16669977] - Anne-Kathrin Pieper, Dieter Haffner, Bernd Hoppe, Katalin Dittrich, Gisela Offner, Klaus-Eugen Bonzel, Ulrike John, Stefan Fründ, Günter Klaus, Amrey Stübinger, Gesche Düker, Uwe Querfeld. A randomized crossover trial comparing sevelamer with calcium acetate in children with CKD.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2006 Apr; 47(4):625-35. doi:
10.1053/j.ajkd.2005.12.039. [PMID: 16564940] - Wajeh Y Qunibi. The CARE study and cardiovascular calcification.
Managed care (Langhorne, Pa.).
2006 Mar; 15(3 Suppl):1-5. doi:
NULL. [PMID: 16604943] - Andrew Otoo, Gregg Little. Controversies in the management of hyperphosphatemia in patients with end-stage renal disease.
Managed care (Langhorne, Pa.).
2006 Mar; 15(3 Suppl):5-8. doi:
NULL. [PMID: 16604944] - NULL. Phosphate binders.
The Medical letter on drugs and therapeutics.
2006 Feb; 48(1228):15-6. doi:
NULL. [PMID: 16467735] - Yao-Lung Liu, Hsin-Hung Lin, Chun-Chen Yu, Huey-Liang Kuo, Ya-Fei Yang, Che-Yi Chou, Po-Wen Lin, Jiung-Hsiun Liu, Pen-Yuan Liao, Chiu-Ching Huang. A comparison of sevelamer hydrochloride with calcium acetate on biomarkers of bone turnover in hemodialysis patients.
Renal failure.
2006; 28(8):701-7. doi:
10.1080/08860220600925388. [PMID: 17162430] - Fatma Nurhan Ozdemir, Ali Akçay, Rengin Elsurer, Siren Sezer, Zübeyde Arat, Mehmet Haberal. Interdialytic weight gain is less with the Mediterranean type of diet in hemodialysis patients.
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
2005 Oct; 15(4):371-6. doi:
10.1053/j.jrn.2005.07.006. [PMID: 16198929] - Krista F Huybrechts, J Jaime Caro, David A Wilson, Judith A O'Brien. Health and economic consequences of sevelamer use for hyperphosphatemia in patients on hemodialysis.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
2005 Sep; 8(5):549-61. doi:
10.1111/j.1524-4733.2005.00049.x. [PMID: 16176493] - Charles R Nolan, Wajeh Y Qunibi. Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis.
Kidney international. Supplement.
2005 Jun; ?(95):S13-20. doi:
10.1111/j.1523-1755.2005.09502.x. [PMID: 15882308] - Eli A Friedman. Consequences and management of hyperphosphatemia in patients with renal insufficiency.
Kidney international. Supplement.
2005 Jun; ?(95):S1-7. doi:
10.1111/j.1523-1755.2005.09500.x. [PMID: 15882307] - Larry A Greenbaum, Ryszard Grenda, Ping Qiu, Irene Restaino, Amy Wojtak, Ana Paredes, Nadine Benador, Joel Z Melnick, Laura A Williams, Isidro B Salusky. Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis.
Pediatric nephrology (Berlin, Germany).
2005 May; 20(5):622-30. doi:
10.1007/s00467-004-1792-6. [PMID: 15785941] - Emiliana Ferramosca, Steven Burke, Scott Chasan-Taber, Carlo Ratti, Glenn M Chertow, Paolo Raggi. Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients.
American heart journal.
2005 May; 149(5):820-5. doi:
10.1016/j.ahj.2004.07.023. [PMID: 15894962] - William F Finn. Phosphorus management in end-stage renal disease.
Seminars in dialysis.
2005 Jan; 18(1):8-12. doi:
10.1111/j.1525-139x.2005.18116.x. [PMID: 15663754] - Basak Coskun, Yunus Saral, Perihan Ozturk, Yelda Karincaoglu, Bengu Cobanoglu. Calcium acetate-induced linear fixed drug eruption.
Dermatology (Basel, Switzerland).
2005; 210(3):244-5. doi:
10.1159/000083961. [PMID: 15785058] - Denis Fouque. Phosphate intake and the CARE study.
Kidney international.
2004 Nov; 66(5):2088; author reply 2088-9. doi:
10.1111/j.1523-1755.2004.989_1.x. [PMID: 15496185] - Wajeh Y Qunibi, Charles R Nolan. Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis: results of the CARE study.
Kidney international. Supplement.
2004 Sep; ?(90):S33-8. doi:
10.1111/j.1523-1755.2004.09006.x. [PMID: 15296505] - Dmitry Babarykin, Inara Adamsone, Diana Amerika, Aldis Spudass, Vladimir Moisejev, Nadezhda Berzina, Linda Michule, Rafail Rozental. Calcium-enriched bread for treatment of uremic hyperphosphatemia.
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
2004 Jul; 14(3):149-56. doi:
10.1053/j.jrn.2004.04.004. [PMID: 15232793] - Wajeh Y Qunibi, Robert E Hootkins, Laveta L McDowell, Micah S Meyer, Matthias Simon, Rodolfo O Garza, Russell W Pelham, Mark V B Cleveland, Larry R Muenz, David Y He, Charles R Nolan. Treatment of hyperphosphatemia in hemodialysis patients: The Calcium Acetate Renagel Evaluation (CARE Study).
Kidney international.
2004 May; 65(5):1914-26. doi:
10.1111/j.1523-1755.2004.00590.x. [PMID: 15086935]